Key Takeaways
- The FDA budget would remain at the FY 2024 level under a Republican spending bill to fund the government for the remainder of FY 2025, marking two straight years with no taxpayer funding boost.
The US Food and Drug Administration would see its second straight year without a boost in taxpayer funds under a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?